Literature DB >> 22956716

Massive neurocysticercosis: encephalitic versus non-encephalitic.

Oscar H Del Brutto, Xavier Campos.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22956716      PMCID: PMC3435335          DOI: 10.4269/ajtmh.2012.12-0162

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


× No keyword cloud information.
Most patients with neurocysticercosis have few intracranial lesions. However, a small subset show development of massive infections that may be divided into encephalitic and non-encephalitic. Proper differentiation of both forms is important because they have different pathogenetic mechanisms and require different therapeutic approaches. The encephalitic form often occurs in children and young women who have not had contact with the parasite until they are infected with a heavy load of Taenia solium eggs.1 In these cases, the host's immune system actively reacts against the parasites. The clinical picture is that of acute encephalitis, and neuroimaging shows multiple degenerating cysticerci and marked brain swelling (Figure 1). Cysticidal drugs are not needed because most parasites will die spontaneously. Moreover, use of these drugs can exacerbate the inflammatory reaction and be harmful to patients.
Figure 1.

Magnetic resonance imaging of patient with encephalitic neurocysticercosis, showing multiple degenerating cysticerci and marked brain swelling.

Magnetic resonance imaging of patient with encephalitic neurocysticercosis, showing multiple degenerating cysticerci and marked brain swelling. In contrast, heavy non-encephalitic neurocysticercosis occurs most often in T. solium carriers who have shown development of mechanisms of immune tolerance to nervous system invasion by cysticerci and in patients with chronic seizure disorders and normal results for neurologic examinations.2 Neuroimaging shows multiple viable cysticerci and no edema (Figure 2). These patients may benefit from cysticidal drug therapy, and some need repeated courses of therapy to overcome the infection. Also, patients must be treated if they are found to be carriers of T. solium.
Figure 2.

Computed tomography of patient with heavy non-encephalitic neurocysticercosis, showing multiple viable cysticerci and no edema.

Computed tomography of patient with heavy non-encephalitic neurocysticercosis, showing multiple viable cysticerci and no edema.
  2 in total

1.  Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. The Cysticercosis Working Group in Perú.

Authors:  H H García; O H Del Brutto
Journal:  Neurology       Date:  1999-10-22       Impact factor: 9.910

2.  Cysticercotic encephalitis: a severe form in young females.

Authors:  R Rangel; B Torres; O Del Bruto; J Sotelo
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

  2 in total
  3 in total

1.  Single parenchymal brain cysticercus: relationship between age of patients and evolutive stage of parasites.

Authors:  Victor J Del Brutto; Oscar H Del Brutto; Elio Ochoa; Héctor H García
Journal:  Neurol Res       Date:  2012-10-11       Impact factor: 2.448

Review 2.  Pediatric neurocysticercosis: current challenges and future prospects.

Authors:  Pratibha Singhi; Arushi Gahlot Saini
Journal:  Pediatric Health Med Ther       Date:  2016-03-08

Review 3.  Disseminated cysticercosis: clinical spectrum, Toll-like receptor-4 gene polymorphisms and role of albendazole: A prospective follow-up of 60 cases with a review of 56 published cases.

Authors:  Abdul Qavi; Ravindra Kumar Garg; Hardeep Singh Malhotra; Amita Jain; Neeraj Kumar; Kiran Preet Malhotra; Pradeep Kumar Srivastava; Rajesh Verma; Praveen Kumar Sharma
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.